VICKI CHEN: Open Payments
NPI 1417351016 · BEVERLY HILLS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,541 in 52 payments from 16 companies in 2025. Trend: 2023 $1,522 · 2024 $1,513 · 2025 $1,541
Food & beverage: $1,446Education: $95
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $386 |
| ABBVIE INC. | 10 | $359 |
| Galderma Laboratories, L.P. | 4 | $211 |
| Arcutis Biotherapeutics, Inc. | 5 | $108 |
| UCB, Inc. | 3 | $94 |
| LEO Pharma Inc. | 4 | $87 |
| Almirall LLC | 2 | $52 |
| REVANCE THERAPEUTICS, INC. | 2 | $37 |
| E.R. Squibb & Sons, L.L.C. | 1 | $35 |
| Lilly USA, LLC | 1 | $35 |
Products named: TREMFYA, BOTOX, Zoryve, Bimzelx, ANZUPGO, Seysara, SKYRIZI, DAXXIFY.
Industry payments across CA — which companies pay providers there.
